MedTrace Logo

The Impact of Opioid and Cannabis Exposure on Fetal Growth

NCT05899101 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-03-20

No results posted yet for this study

Summary

Individually, both opioid and cannabis exposure during pregnancy are associated with changes in fetal growth. The extent to which opioid and cannabis exposure affect fetal growth is unknown. The Investigators hypothesize that the combination of both substances will impact placental function and subsequent fetal growth more severely than either substance alone. The primary objective is to determine the extent to which fetal growth profiles in opioid-exposed pregnancies are influenced by cannabis exposure. This prospective cohort study will consist of opioid-exposed pregnancies and pregnancies without opioid exposure recruited from 5 obstetrical clinics from across Ontario. A total of 546 participants will be recruited.

Conditions

  • Pregnancy Related
  • Substance Use
  • Fetal Growth Retardation
  • Placenta Diseases

Sponsors & Collaborators

  • University of Ottawa

    collaborator OTHER

  • Dr. Laura Gaudet

    lead OTHER

Principal Investigators

  • Laura Gaudet, MD · Queen's University

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-23
Primary Completion
2024-10-15
Completion
2024-11-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05899101 on ClinicalTrials.gov